you are here: HomeNewsBusiness

Coronavirus-led lockdown | Cosmetics retailer Nykaa suspends operations across India

Nykaa said it will not be able to make payments of outstanding invoices to all vendors and partners in time, citing a disruption in its cash flow due to the ongoing lockdown as reason for the same

March 31, 2020 / 05:18 PM IST

Leading cosmetics retailer Nykaa has suspended all operations and temporarily shut down its retail stores, corporate offices and warehouses.

The company said in a statement on March 31 that the step has been taken in light of the novel coronavirus, or COVID-19, outbreak, following which a nationwide lockdown was announced by Prime Minister Narendra Modi on March 24.

To track all live updates from the coronavirus pandemic, click here

"Most state governments have issued directives to temporary shutdown establishments, retail stores, logistics, business operations, etc. We are adhering to every instruction of the government and the health department and will continue to do so," it added.

Nykaa also said it will not be able to make payments of outstanding invoices to all vendors and partners in time, citing a disruption in its cash flow due to the ongoing lockdown as reason for the same.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"Like all other consumer-facing businesses, we now face a situation where our cash flow and income are impacted, but on the other hand, our expenses remain constant," it explained.

Follow our full coverage here
Moneycontrol News
first published: Mar 31, 2020 05:18 pm

stay updated

Get Daily News on your Browser
Sections